x Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR):final results from a randomised, open-label, phase 3 trial Link logo PDF logo

Choueiri, Toni K.; Escudier, Bernard; Powles, Thomas; Tannir, Nizar M.; Mainwaring, Paul N.; Rini, Brian I.; Hammers, Hans J.; Donskov, Frede; Roth, Bruce J.; Peltola, Katriina; Lee, Jae Lyun; Heng, Daniel Y. C.; Schmidinger, Manuela; Agarwal, Neeraj; Sternberg, Cora N.; McDermott, David F.; Aftab, Dana T.; Hessel, Colin; Old, Christian Scheff; Schwab, Gisela

Lancet Oncology Volume 17, Issue 7, Pages 917–927, DOI: 10.1016/S1470-2045(16)30107-3

  • 31 tweets
  • 20 news
  • 57 Mendeley readers

Geographics of Mendeley readers

By country: 4

Unknown: 53


Readers by professional status:


Readers by discipline:

Site data sourced from Altmetric.com and CSC (VIRTA)